10x Genomics, Inc.
TXG
Clasificación en acciones
#2230
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012... Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Precio por acción
$69.74
Última sincronización: 2026-10-16
Capitalización bursátil
$9.09B
Cambio (1 día)
-3.67%
Cambio (1 año)
489.48%
País
US
Comercio 10x Genomics, Inc. (TXG)
Categoría
Healthcare
EPS de 10x Genomics, Inc. (TXG)
EPS a fecha de June 2026 TTM: $-0.59
Según los últimos informes financieros y el precio de las acciones de 10x Genomics, Inc., el EPS actual de la empresa (TTM) es $-0.59. Al final del año 2024, la empresa tenía un EPS de $-1.52 una disminución en comparación con al EPS de 2023, que fue de $-2.18.
Historial de EPS de 10x Genomics, Inc. desde 2017 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $-0.59 | 68.57% |
| 2025 | $-0.35 | -76.97% |
| 2024 | $-1.52 | -30.28% |
| 2023 | $-2.18 | 49.32% |
| 2022 | $-1.46 | 175.47% |
| 2021 | $-0.53 | -90.13% |
| 2020 | $-5.37 | 571.25% |
| 2019 | $-0.80 | -90.48% |
| 2018 | $-8.40 | 418.52% |
| 2017 | $-1.62 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $3.48 | -689.83% |
US
|
|
| $1.79 | -403.63% |
AU
|
|
| $1.43 | -342.37% |
US
|
|
| $-1.43 | 142.37% |
US
|
|
| - | - |
US
|
